Silicos, A Computational Drug Design Biotech, Appoints Dr. Jack Elands As Chief

Belgian biotech to further commercialize its computational fragment based drug design platform as well as its MDM2 and PTP-1B drug development programs. Diepenbeek, Belgium: 29 June 2009 -- Today Silicosâ?? CEO, Dr. Wilfried Langenaeker announced the appointment of Dr. Jack Elands as the companyâ??s...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Palestinian uncle says Fort Hood suspect loved US, but work as psychiatrist drove - Metronews

G20 vows to spur fragile growth - BBC

Tory hostility to EU extradition law 'risks new Costa del Crime' - Observer

Family shock at Briton's bar murder A British father on a road-trip through the - Wharfvalley

Local families mourn soldiers' lives cut short - Chicago Tribune

Featured Members

Mark Palmer
Founder
Internet consultancies

David Hood
Director
Marketing/Public Relations

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map